New method for measuring blood flow in the brain non-invasively
Development of highly parallelized interferometric near-infrared spectroscopy for the real-time non-invasive measurement of cerebral blood flow
This study is testing a new, non-invasive way to measure blood flow in the brain using light, which could help doctors quickly diagnose and treat strokes without the need for any painful procedures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Neuralenz, INC NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10920028 on NIH RePORTER |
What this research studies
This research focuses on developing a novel technique using interferometric near-infrared spectroscopy to measure cerebral blood flow in real-time without the need for invasive procedures. By utilizing advanced optical methods, the goal is to provide continuous and accurate assessments of blood flow in the brain, which is crucial for timely stroke diagnosis and treatment. This approach aims to overcome the limitations of current imaging techniques that can delay critical interventions for stroke patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals over 21 years old who are experiencing symptoms of a stroke or have been diagnosed with a cerebrovascular condition.
Not a fit: Patients with conditions that do not affect cerebral blood flow or those who are not experiencing acute stroke symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the speed and accuracy of stroke diagnosis, leading to better treatment outcomes for patients.
How similar studies have performed: While optical methods for assessing cerebral blood flow have shown promise, this specific approach is novel and has not been extensively tested in clinical settings.
Where this research is happening
New York, United States
- Neuralenz, INC — New York, United States (Active)
Researchers
- Principal investigator: Kholiqov, Oybek — Neuralenz, INC
- Study coordinator: Kholiqov, Oybek
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.